Trial product was prematurely discontinued because of AEs by 7.1% ( n = 13), 8.8% ( n = 16), 13.3% ( n = 24), and 2.7% ( n = 5) of patients for oral semaglutide 3, 7, and 14 mg and placebo, respectively, with gastrointestinal disorders being the most frequent cause (Supplementary Table 6)
Make sure that you get these compounds from medical providers whom you can trust so you know that you're getting what it says it is.
Trebble TM, Arden NK, et al
Tirzepatide delays gastric emptying, which means "fasting" might need to be longer than the typical 8-12 hours
The Healthy Weight Loss module is designed specifically for patients with clinical obesity (Rubino et al., 2023) who are motivated to pursue healthy and sustainable weight loss
PlexusDx emphasizes that symptom reportingincluding any chest sensationshelps providers adjust your dose or timing to maximize tolerability